Aprio Wealth Management, LLC Astrazeneca PLC Transaction History
Aprio Wealth Management, LLC
- $514 Million
- Q2 2024
A detailed history of Aprio Wealth Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aprio Wealth Management, LLC holds 4,302 shares of AZN stock, worth $333,275. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,302
Previous 3,660
17.54%
Holding current value
$333,275
Previous $247,000
35.63%
% of portfolio
0.07%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.03 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.3 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.14 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.84 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.36 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...